Daewon Pharmaceutical Co., Ltd. (003220.KS) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.4x

Market Cap

KRW 171.36B

MomentumView details →

1D Return

−1.36%

YTD Return

−32.47%

RSI (14)

55.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−7.4x

Market Cap

KRW 171.36B

RSI (14)

55.5

MomentumView details →

1D Return

−1.36%

YTD Return

−32.47%

ProfitabilityView details →

Gross Margin

44.88%

Net Margin

0.43%

EBITDA Margin

−6.66%

ROE (TTM)

0.98%

ROA (TTM)

0.46%

Asset Turnover

1.05x

GrowthView details →

Revenue YoY

+1.86%

EPS YoY

−67.94%

FCF YoY

−91.86%

Revenue CAGR 3Y

+8.14%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

KRW 187.92

EPS Surprise

63.82%

Beats (12Q)

1/12

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

63.82%

Rev Surprise

0.00%

Capital & dividendView details →

Debt/Equity

0.71x

Current Ratio

1.12x

Quick Ratio

0.62x

Div Yield

3.13%

Div Rate

KRW 250.00

Div Growth 1Y

−16.67%

Financials snapshotView financials →

Revenue (TTM)

614.84B

Net Income (TTM)

2.63B

Op. CF (TTM)

7.25B

Latest newsMore news →

No recent news for 003220.KS.

Similar companies

JW Lifescience Corporation234080.KS FutureChem Co.,Ltd220100.KQ AptaBio Therapeutics Inc.293780.KQ BNC Korea Co., Ltd.256840.KQ Daihan Pharmaceutical Co.,Ltd.023910.KQ REYON Pharmaceutical Co., Ltd.102460.KS Find similar companies →

Latest newsMore news →

No recent news for 003220.KS.